A Storm Will Follow the Lull
Newsflow around the US and state governments' antitrust investigations of the generic drug industry has been quiet since mid-December. Some lull is...
846 Views
Indictments Starting to Appear
The US Department of Justice (DOJ) filed charges (attached) against two former senior executives of Heritage Pharmaceuticals, a subsidiary of Pune,...
426 Views
Laurus Labs: Final Thoughts
The company has announced a price range of Rs 426 - 428 per share for its listing with bidding set to open on 6 December and closing on 8 December...
354 Views
Laurus Labs IPO Overview
India-based Laurus Labs has filed for a listing on the BSE and NSE, and reportedly plans to raise up to Rs300 crore for debt repayment and general...
340 Views
No Trump Cards for This Risk
This Insight is an update from Generic Drug Antitrust Inquiry: A Primer. Several generic drug companies caught up in government investigations into...
350 Views